Provided by Tiger Fintech (Singapore) Pte. Ltd.

Novel Coronavirus Treatment

1,007.093
-14.869-1.45%
Number of Gainers:11
Number of Losers:8
Number of Flat:13
PE:- -
High:1,021.554
Open:1,021.382
Low:1,002.096
Close:1,021.962
Loading ...

BRIEF-CSL Says Swissmedic Approves Andembry To Prevent Recurrent Attacks Of Hereditary Angioedema

Reuters
·
27 Feb

Australian Competition Regulator Authorizes Supermarkets' Collaboration on Stockpiled Soft Plastics Recycling

MT Newswires Live
·
27 Feb

Coles Group Chairman to Retire; Successor Named; Shares Hit All-Time High

MT Newswires Live
·
27 Feb

Strong Result From Coles Expected to Boost Shares -- Market Talk

Dow Jones
·
27 Feb

Investors in Genetic Signatures (ASX:GSS) from three years ago are still down 51%, even after 16% gain this past week

Simply Wall St.
·
27 Feb

Coles share price lifts off on dividend boost

MotleyFool
·
27 Feb

Mesoblast Sets Ryoncil® Price Based on Economic Value of Treatment With Planned Product Availability This Quarter

THOMSON REUTERS
·
27 Feb

Press Release: Mesoblast Sets Ryoncil(R) Price Based on Economic Value of Treatment With Planned Product Availability This Quarter

Dow Jones
·
27 Feb

Australia's Coles profit meets Street view, dividend highest in over 5 years

Reuters
·
27 Feb

Australia's Coles' chairman James Graham to retire

Reuters
·
27 Feb

BRIEF-Coles Says Chairman James Graham Will Retire From Board Of Coles

Reuters
·
27 Feb

Coles Group - Chairman James Graham Will Retire From Board of Coles Effective 30 April

THOMSON REUTERS
·
27 Feb

Coles Group Ltd - Appointed Peter Allen as Chairman-Elect to Succeed Mr Graham on 1 May

THOMSON REUTERS
·
27 Feb

Coles Chair Succession-Col.ax

THOMSON REUTERS
·
27 Feb

Mesoblast Ltd - Hy Loss Attributable $47.9 Mln

THOMSON REUTERS
·
27 Feb

Australia's Coles first-half profit slips 3%

Reuters
·
27 Feb